Beyond weight loss, GLP-1 agents reduce circulating insulin levels, attenuate insulin-like growth factor signaling, and lower systemic inflammatory markers
GLP-1 Diabetes Medications Linked to Lower Epilepsy Risk The reduced epilepsy risk was seen within one year of treatment and persisted over time, especially with semaglutide
So, for this reason, there are a lot of serums, facials, and high-end creams that have entered the market
: , , ,
Ozempic and hypothyroidism The weight loss associated with GLP-1s like Ozempic can be beneficial for people with hypothyroidism, says Elizabeth Van Dril, Pharm.D., a clinical pharmacist with the University of Illinois Hospital and Health Sciences System
Tahimic CG, Long RK, Kubota T, Sun MY, Elalieh H, Fong C, et al